{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:41:47Z","timestamp":1790106107655,"version":"4.0.1"},"reference-count":46,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T00:00:00Z","timestamp":1239753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:p>Malignant pleural mesothelioma (MPM) is difficult to diagnose at an early stage. The present study attempted to obtain a tumor\u2010specific antibody against MPM derived from tumor\u2010infiltrating B lymphocytes in MPM by using a xenotransplanted severe combined immunodeficiency (SCID) mouse model, and to identify the antigens recognized by the antibodies. Among the antigen\u2013antibody relationships, the clinical usefulness of antibody titers in the sera was evaluated from the viewpoint of diagnosis of MPM and monitoring of therapeutic effects. Tumor tissue specimens from two patients with MPM were engrafted subcutaneously in SCID mice and blood samples were obtained and pooled every 2\u00a0weeks after xenotransplantation until 14\u00a0weeks when the mice were killed. A cDNA library was constructed from the mRNA of a MPM cell line (K921MSO). Immunoscreening of the libraries was carried out by serological identification of antigens by a recombinant expression cloning method (SEREX) and four antigens were identified as MPM\u2010associated antigens. Among them, antibody titers against two antigens, Gene\u2010X and thrombospondin\u20102 (THBS\u20102), were analyzed by phage plaque assay as the first step. ELISA systems correlated with the phage plaque assay to detect antibody titers against the two antigens were constructed using 20\u2010mer peptides of the antigen\u2010coding genes. The cut\u2010off value was decided by the average and standard deviation of normal healthy persons. Antibody against Gene\u2010X was detected in 10 out of 18 (55.6%) mesothelioma patients and antibody against THBS\u20102 was detected in 16 out of 18 (88.9%) mesothelioma patients. No patients with lung cancer regardless of asbestos exposure exhibited positive antibody titer against the two antigens. Furthermore, the serum antibody titers decreased after surgical treatment of MPM and increased after recurrence of the disease. The titers of the antibodies against Gene\u2010X and THBS\u20102 could be used as tumor markers for the diagnosis and follow up of patients with MPM. (<jats:italic>Cancer Sci<\/jats:italic> 2009; 100: 1326\u20131334)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2009.01181.x","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T05:41:45Z","timestamp":1239774105000},"page":"1326-1334","source":"Crossref","is-referenced-by-count":18,"title":["Malignant mesothelioma\u2010associated antigens recognized by tumor\u2010infiltrating B cells and the clinical significance of the antibody titers"],"prefix":"10.1111","volume":"100","author":[{"given":"Yoshiki","family":"Shigematsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hanagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Ichiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Takenoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sugio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,10]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90462-X"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690105"},{"key":"e_1_2_7_4_2","volume-title":"Vital Statistics of Japan 2003","author":"Statistics and Information Department Labour and Welfare of Japan","year":"2003"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-007-0293-x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9900"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.8.1157"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.1.159"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861001)58:7<1540::AID-CNCR2820580727>3.0.CO;2-5"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(99)70469-1"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2005.00119.x"},{"key":"e_1_2_7_12_2","first-page":"1827","article-title":"Effect of IgG produced by tumor\u2010infiltrating B lymphocytes on lung tumor growth","volume":"26","author":"Mizukami M","year":"2006","journal-title":"Anticancer Res"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3889"},{"key":"e_1_2_7_14_2","first-page":"1751","article-title":"Tumor\u2010infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer","volume":"62","author":"Yasuda M","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.4.895"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.1.282"},{"key":"e_1_2_7_17_2","first-page":"595","article-title":"Antibody specific for lung cancer cells detected in sera of patients with bronchogenic carcinoma","volume":"74","author":"Yasumoto K","year":"1983","journal-title":"Gann"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1983.16"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.8.1163"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01533513"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/07357900009012192"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.7.899"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.1.113"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.01.008"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.01.004"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.01.012"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.105.2.625"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.108.2.729"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1993.1308"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M600297-MCP200"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207551"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.3.219"},{"key":"e_1_2_7_33_2","first-page":"1013","article-title":"Histopathology and clinical assessment correlate with the cysteine\u2010serine\u2010valine\u2010threonine\u2010cysteineglycine (CSVTCG) receptor of thrombospondin\u20101 in breast tumors","volume":"12","author":"Roth JJ","year":"1997","journal-title":"Histol Histopathol"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1994.tb02904.x"},{"key":"e_1_2_7_35_2","first-page":"1411","article-title":"Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer","volume":"2","author":"Ohta Y","year":"1996","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P"},{"key":"e_1_2_7_37_2","first-page":"4948","article-title":"Overexpression of the cochaperone CHIP enhances Hsp70\u2010dependent folding activity in mammalian cells","volume":"23","author":"Kampinga HH","year":"2003","journal-title":"Mol"},{"key":"e_1_2_7_38_2","first-page":"28\u00a0441","article-title":"CHIP chaperones wild type p53 tumor suppressor protein","volume":"28","author":"Veenu T","year":"2007","journal-title":"J Biol Chem"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.4.559"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V651354"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005950070014"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045541"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2304"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000056981.16578.C3"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.08.028"},{"key":"e_1_2_7_46_2","first-page":"20","article-title":"Preclinical evaluation of MORAb\u2010009, a chimeric antibody targeting tumor\u2010associated mesothelin","volume":"19","author":"Hassan R","year":"2007","journal-title":"Cancer Immun"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.22.5.3930"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2009.01181.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2009.01181.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:12:07Z","timestamp":1697184727000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2009.01181.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,10]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1349-7006.2009.01181.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01181.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,10]]}}}